Novelos Therapeutics, Inc. NVLT Company Overview Stock

New Post Public Reply Private Reply Replies (0) Message Board

Sep 14, 2013 at 6:43 PM

Novelos Therapeutics, Inc. NVLT Company Overview

Stock Message Board http://investorshangout.com/search?q=NVLT&...mp;yt1=Go!

Novelos Therapeutics, Inc. NVLT Current Price and Quotes
Last Price 0.399
Previous Close 0.399 Open 0.399
Daily Range 0.399 - 0.399 52wk Range 1.08 - 0.32
Volume 225 Dividend N/A
Average Vol (3m) 15,161 Yield N/A
Novelos Therapeutics, Inc. NVLT
Company Information

3301 Agriculture Dr.
Madison, WI 53716

Website: http://www.novelos.com
Phone: 608-441-8120
Email: pgenn@novelos.com

Novelos Therapeutics, Inc. NVLT
We are a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer. Our cancer-targeted compounds are selectively taken up and retained in cancer cells, including cancer stem cells, versus normal cells. Thus, our therapeutic compounds appear to directly kill cancer cells while minimizing harm to normal cells. This offers the potential for a paradigm shift in cancer therapy by providing efficacy versus all three major drivers of mortality in cancer: primary tumors, ...

Novelos Therapeutics, Inc. NVLT
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jun 30, 2013 10-Q
CIK 0001279704
Fiscal Year End 12/31
OTC Marketplace OTCQX U.S.
Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 1996
Employees 17 a/o Jan 01, 2012
Company Officers/Contacts

Harry S. Palmin CEO
Joanne M. Protano CFO, Vice President, Treasurer
Christopher J. Pazoles SVP, R&D
J. Patrick Genn VP, Investor Rel.
Company Directors

Stephen A. Hill Chairman
Thomas Rockwell Mackie
James S. Manuso
John Neis
John E. Niederhuber
Howard M. Schneider
Michael F. Tweedle
Jamey P. Weichert
Company Notes

Formerly=Common Horizons, Inc. until 6-05
Service Providers

DAD/PAL
C. K. Cooper & Company
18300 Von Karman Ave; Suite 700
Irvine, CA, 92612
United States

Auditor/Accountant
Grant Thornton
200 South Orange Avenue
Suite 2050
Orlando, FL, 32801
United States

Legal Counsel
Foley Hoag LLP
World Trade Center West
Boston, MA, 02210
United States

Investor Relations Firm
Lippert/Heilshorn & Associates
800 Third Avenue
New York, NY, 10022
United States

Novelos Therapeutics, Inc. NVLT
NVLT Security Details

Share Structure

Market Value1 $22,901,801 a/o Sep 13, 2013
Shares Outstanding 57,397,997 a/o Aug 09, 2013
Float 11,762,442 a/o Jan 31, 2012
Authorized Shares 150,000,000 a/o Jan 31, 2012
Par Value 0.001
Shareholders

Shareholders of Record 285 a/o Dec 01, 2011
Security Notes

Capital Change=shs increased by 4 for 1 split Ex-date=06/13/2005. Rec date=05/25/2005. Pay date=06/10/2005.
Capital Change=shs decreased by 1 for 153 split. Pay date=04/11/2011.
Short Selling Data

Short Interest 4,175 (-20.51%)
Aug 30, 2013
Significant Failures to Deliver No
Transfer Agent(s)

American Stock Transfer & Trust Company

Novelos Therapeutics, Inc. NVLT Recent News

Jul 29, 2013 Novelos Therapeutics Announces Leadership Transition

Novelos Therapeutics, Inc. NVLT Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue - - - 33
Cost of Revenue - - - -
Gross Profit - - - 33
Operating Expenses

Research and Development 5,123 3,599 2,984 8,080
Sales, General and Admin. 3,632 2,692 1,157 2,182
Non-Recurring Items - 746 53 -
Other - - - -
Operating Income (8,755) (7,038) (4,194) (10,229)
Income From Continuing Operations

Add'l Income/Expense Items (34) 32 200 (12,044)
Earnings Before Interest and Tax (8,789) (7,005) (3,994) (22,273)
Interest Expense 8 430 566 -
Earnings Before Tax (8,797) (7,435) (4,560) (22,273)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (8,797) (7,435) (4,560) (22,273)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (8,797) (7,435) (4,560) (22,273)
Preferred Stock and Other Adjustments (543) - - (4,010)
Net Income Applicable to Common Shareholders (9,340) (7,435) (4,560) (26,284)

NVLT Novelos Therapeutics, Inc. Research DD Guide

NVLT Novelos Therapeutics, Inc. Stock Message Board http://investorshangout.com/search?q=NVLT&...mp;yt0=Go!
NVLT Novelos Therapeutics, Inc. Stock Quote http://www.otcmarkets.com/stock/NVLT/quote
NVLT Novelos Therapeutics, Inc. Stock Chart http://www.otcmarkets.com/stock/NVLT/chart
NVLT Novelos Therapeutics, Inc. Company Info http://www.otcmarkets.com/stock/NVLT/company-info
NVLT Novelos Therapeutics, Inc. Recent News http://www.otcmarkets.com/stock/NVLT/news
NVLT Novelos Therapeutics, Inc. Financials http://www.otcmarkets.com/stock/NVLT/financials
NVLT Novelos Therapeutics, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/NVLT/filings
NVLT Novelos Therapeutics, Inc. Short Sales http://www.otcmarkets.com/stock/NVLT/short-sales
NVLT Novelos Therapeutics, Inc. Insider Disclosure http://www.otcmarkets.com/stock/NVLT/insider-transactions
NVLT Novelos Therapeutics, Inc. Research Reports http://www.otcmarkets.com/stock/NVLT/research
NVLT Novelos Therapeutics, Inc. Summary http://finance.yahoo.com/q?s=NVLT
NVLT Novelos Therapeutics, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=NVLT+Historical+Prices
NVLT Novelos Therapeutics, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=NVLT
NVLT Novelos Therapeutics, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=NVLT+Basic+Chart
NVLT Novelos Therapeutics, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=NVLT+Basic+Tech.+Analysis
NVLT Novelos Therapeutics, Inc. Headlines http://finance.yahoo.com/q/h?s=NVLT+Headlines
NVLT Novelos Therapeutics, Inc. Press Releases http://finance.yahoo.com/q/p?s=NVLT+Press+Releases
NVLT Novelos Therapeutics, Inc. Company Profile http://finance.yahoo.com/q/pr?s=NVLT+Profile
NVLT Novelos Therapeutics, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=NVLT+Key+Statistics
NVLT Novelos Therapeutics, Inc. Industry http://finance.yahoo.com/q/in?s=NVLT+Industry
NVLT Novelos Therapeutics, Inc. Major Holders http://finance.yahoo.com/q/mh?s=NVLT+Major+Holders
NVLT Novelos Therapeutics, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=NVLT+Insider+Transactions
NVLT Novelos Therapeutics, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=NVLT+Insider+Roster
NVLT Novelos Therapeutics, Inc. Income Statement http://finance.yahoo.com/q/is?s=NVLT
NVLT Novelos Therapeutics, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=NVLT
NVLT Novelos Therapeutics, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=NVLT+Cash+Flow&annual
NVLT Novelos Therapeutics, Inc. Nasdaq http://www.nasdaq.com/symbol/NVLT
NVLT Novelos Therapeutics, Inc. Market Watch http://www.marketwatch.com/investing/stock/NVLT
NVLT Novelos Therapeutics, Inc. Bloomberg http://www.bloomberg.com/quote/NVLT:US
NVLT Novelos Therapeutics, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=NVLT
NVLT Novelos Therapeutics, Inc. Bussinessweek http://investing.businessweek.com/research/st...icker=NVLT
NVLT Novelos Therapeutics, Inc. Barchart http://www.barchart.com/quotes/stocks/NVLT
NVLT Novelos Therapeutics, Inc. OTC Short Report http://otcshortreport.com/index.php?index=NVLT
NVLT Novelos Therapeutics, Inc. Investopedia http://www.investopedia.com/markets/stocks/NVLT/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cowfest 2026 Delighted by Frederick's Flying Cows

Moo-ving Towards a New Record Alright, listen up. This fall, there's a bovine spectacle coming to Maryland that's more than just a trip down to the fairgrounds—it's Cowfest 2026, baby! Now, if you're scratching your head thinking this is just another seasonal shindig, you're underestimating what's mooing across Frederick County. The Flying Cows are ready to take the...

Acqualina Resort's Sustainable Commitment Earns Praise

Sustainability at the Heart of Luxury Spotlight's on Acqualina Resort again. The folks there have snagged the 2026 VERIFIED™ Responsible Hospitality badge from Forbes Travel Guide for the third straight year. Means they’re more than just a pretty face down in Miami. This accolade puts them slap bang among the best in sustainable luxury. Forbes doesn’t just hand...

Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

HumanView Relaunch: LEAP Group Decodes Customer Signals

Understanding Customer Signals Like Never Before Well, here's one for the ol' playbook. The LEAP Group just dusted off their tool, HumanView, like an old car getting a fresh coat of paint and an engine overhaul. It's been rebuilt from the ground up, promising to turn those random blips of online chatter into actionable business insights. Not the same old dashboard mumbo...

FOX News Revamps 2026 Election Coverage Playbook

Revamped Coverage: More Than Just Breaking News Yeah, everyone's clamoring about the midterms, but Fox News is doing more than just flipping on the camera and breaking the news every few minutes this year. They're rolling out the big guns: AI chatbots, flashy graphics, and special shows across multiple platforms. The point? To get viewers practically hooked and give 'em...

Darden Faces Class Action Over Reimbursement Failures

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

DCK Reveals Versatile Battery-Powered Garden Tools in 2026

Battery-Powered Revolution in Louisville The treadmill of lawn care just took a high-tech spin with DCK Tools strutting their stuff at Equip Exposition 2026. Unrolled at the Kentucky Exposition Center, the event from October 21 to 23 was brimming with their battery-powered wares that aim to take the grunt out of yard work. Game-Changing Range of Garden Tools DCK's decked...

Master Sommeliers and Italian Producers Clash on Wine Lists

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

York Space Systems Class Action: Deadline Approaches

Rapid Deadline: October 30 Looms for York Space Systems You blink, and you might miss the deadline. We’re just a step away from deadline day in the York Space Systems’ class action lawsuit. If you've got skin in this game, time's not on your side. Shareholders, particularly those who hopped on the York Space train via their IPO back in January 2026, are staring down...

Gildan Faces Lawsuit: Allegations of Deceptive Practices Shake Investors

Gildan's Troubles Unveiled The financial jungle can be a pretty treacherous place, and Gildan Activewear Inc. (NYSE: GIL) just found out how fickle the market can be. An 18.7% nosedive in Gildan's stock price after a securities fraud class action came knocking—if that isn't enough to stir up a hornet’s nest among investors, I don’t know what is. The Catalyst:...